FAQs

Innovita RBT Therapeutics
Peptides

Unlocking the Future of Personalised Health and Regeneration

Peptides are short chains of amino acids, the essential building blocks of proteins, naturally produced in the body to regulate biological processes. These small but powerful molecules serve as messengers in the body, sending signals to cells and tissues to trigger critical functions such as healing, regeneration, metabolism, fat reduction, immune support, and anti-ageing.

At Reverse Body Time, we specialise in the development and production of injectable peptides—a superior method of peptide delivery designed for enhanced absorption, potency, and results. Unlike edible peptides that must pass through the digestive system, injectable peptides bypass this barrier entirely, allowing for direct absorption into the bloodstream and ensuring maximum efficacy.

Innovita RBT Therapeutics
Innovita RBT Therapeutics

Our state-of-the-art laboratories and patented formulations allow us to lead the way in precision peptide therapies, offering solutions that target specific health goals with scientific accuracy. Backed by peer-reviewed research and our deep commitment to innovation, our peptides are transforming the fields of regenerative medicine, longevity science, and performance optimisation.
 
We provide an extensive overview of our peptides, broken into categories to address various health goals. Each section explains the science and benefits in a clear, accessible way so everyone—from athletes to biohackers to individuals seeking improved wellness—can understand their potential. 

Peptides and Manufacturing

Quality and Purity

The purity level of our BPC-157 and TB-500 peptides exceeds 98%, as determined by High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) analysis.

Yes, each batch undergoes rigorous testing, and a Certificate of Analysis (CoA)is provided upon request. This includes purity, identity confirmation, and contaminant screening.

  • Impurities: Tested via HPLC to detect unwanted by products.
  • Heavy metals: Measured using Inductively Coupled Plasma Mass Spectrometry (ICP-MS).
  • Endotoxins: Quantified using the Limulus Amebocyte Lysate (LAL) assay, ensuring compliance with pharmaceutical-grade standards.

Yes, upon request we perform third-party independent validation through accredited laboratories to confirm product quality. Reports are available upon request for transparency.

Our peptides are chemically synthesized via solid-phase peptide synthesis (SPPS) to ensure high purity and consistency.

Manufacturing Standards & Compliance

Our peptides are manufactured in a GMP-certified laboratory following ISO 9001 quality management standards.

Yes, our facility is GMP-certified, and we can provide documentation upon request.

Yes, we comply with ISO 9001, ISO 13485 (if applicable to medical devices)and GMP guidelines.

Yes, all peptides are manufactured in ISO-classified cleanrooms with rigorous aseptic handling.

Yes, upon request.

  • Raw material testing: Ensures high-quality precursors.
  • In-process monitoring: Real-time check during synthesis.
  • Final QC testing_ HPLC/MS, endotoxin and sterility tests.
  • Stability testing: Ensures long-term efficiency.

Stability & Storage

Read to use injectable pen Peptides: 12 months when stored property.

  • Injectable Pen Peptides: Keep at -8/ +4°C (refrigerated) and avoid repeated freeze-thaw cycles.
  • Transportation: Can be in transport for up to 7 days in room temperature.

Yes, we conduct accelerated stability studies to ensure peptides maintain integrity under various conditions.

Yes, upon request, we can produce bigger quantities lyophilized, as standard we produce ready to use injectable pen peptides for full closed quality control circle and user convenience.

Regulatory & Legal Compliance

Yes, our peptides comply with EU GMP standards.

Yes, as synthesized bioactive compounds for research purposes.

Our standard peptides are pure, without unnecessary additives. However, we offer custom formulas with excipients if required.

Some of our produced peptides are included in ongoing clinical studies.

Pricing & Scalability

Our minimum order quantity depends on the peptide, but generally starts at 100 pcs. We are flexible to discuss smaller starting orders? 

Yes, we offer partner pricing with bulk discounts from 300 pcs.

Yes, our production ensures a continuous supply.

Standard shipping to Sweden takes 1- 3 business days, with DHL medical.

Customer & After-Sales Support

If a batch fails QC testing, it is discarded, and a replacement batch is produced immediately.

Yes, we offer full replacements or refunds for any product that fails quality specifications. 

Yes, we can provide upon agreement with other clients, without disclosing their names. 

Yes, upon request.

Treatment Protocols & Scientific Evidence

Mesenchymal Stem Cell (MSC) Therapy:

  • Source: Typically derived from umbilical cord tissue.
  • Administration: Intravenous (IV) or intra-articular (joint injections)
  • Dosing: Typically, 10-100 million cells per session, depending on condition.
  • Frequency: Typically, 1-3 sessions, spread over days, weeks or months.


Exosome Therapy:

  • Source: MSC derived, rich in proteins, lipids and nucleic acids.
  • Administration: IV fusion, direct tissue injection or topical application.
  • Dosing: Microgram (μg) levels, condition-dependent.
  • Frequency: Every- 4-8 weeks, based on patient response.
  • Osteoarthritis: Significant pain reduction & improved mobility.
  • Parkinson’s Disease: MSC-derived neural progenitor cells restored dopamine production.
  • Crohn’s Disease: MSC therapy healed perianal fistulas in refractory cases.
  • Myocardial Infarction: MSCs improved heart function & reduced scar tissue.
  • Diabetes: MSCs reduced insulin dependence & enhanced pancreatic function.
  • Liver Cirrhosis: MSC therapy improved liver function & reduced fibrosis.

Expected Outcomes:

  • Pain & inflammation reduction
  • Improved joint mobility & function
  • Potential cartilage regeneration


Risks:

  • Mild injection site reactions
  • Rare immune response or infections (low risk with GMP-certified products)
  • No tumour formation risk (MSCs do not proliferate uncontrollably)

Yes, each batch undergoes sterility, mycoplasma and endotoxin testing.

Yes, using:

  • Protein assays
  • Nano-particle tracking
  • Functional assays

Customer & After-Sales Support

Yes, all treatments comply with:

  • EU Clinical Trials Regulation (EU CTR 536/2014)
  • EU Medical Devices Regulation (EU MDR 2017/745)
  • MSC & Exosome therapies are offered under EU ATMP regulation via Hospital Exemption.
  • RBT holds all ATMP licences for its products.

No special clearance is required for standard treatments.

Yes, as long as treatment is conducted within the EU (e.g. Lithuania).

Yes, all medical and legal documents are supplied.

Patient Safety & Medical Standards

  • Blood tests
  • Immune profiling
  • Medical history review
  • Regular biomarker tracking
  • Imaging scans
  • Patient-reported outcomes
  • Sterile environments
  • Single-use medical devices
  • Medical team available 24/7
  • No serious adverse reactions reported to date

Additional Medical & Scientific Training

  • Yes, training includes:
  • Dosing guidelines
  • Patient selection criteria
  • Side-effect management
  • Clinical applications for anti-aging & regenerative medicine.
Innovita RBT Therapeutics

Book a Free Consultation

Further information about the efficacy, safety and eligibility of these Cell Immunotherapy treatments will be provided during consultations once the patient has provided their full medical history and status to our specialists.


How did you hear about us?


*All fields are required.

Please only genuine Medical Enquires to use the Contact form, for all other enquiries please email us at info@innovita-rbt-therapeutics.com